ASO Author Reflections: Clinical Implications of Programmed Death-Ligand 2 (PD-L2) Expression as an Independent Prognostic Marker in Lung Adenocarcinoma: Different Characteristics of PD-L2-Positive Patients from Those with Programmed Death-Ligand 1
Crossref DOI link: https://doi.org/10.1245/s10434-019-07680-6
Published Online: 2019-07-31
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Takamori, Shinkichi
Takada, Kazuki
Maehara, Yoshihiko
Text and Data Mining valid from 2019-07-31
Version of Record valid from 2019-07-31
Article History
Received: 23 July 2019
First Online: 31 July 2019
Disclosures
: Shinkichi Takamori, Kazuki Takada, and Yoshihiko Maehara have no conflicts of interest to disclose.